Your browser doesn't support javascript.
loading
Breast-cancer mortality in screened versus unscreened women: Long-term results from a population-based study in Queensland, Australia.
Dunn, Nathan; Youl, Philippa; Moore, Julie; Harden, Hazel; Walpole, Euan; Evans, Elizabeth; Taylor, Kate; Philpot, Shoni; Furnival, Colin.
  • Dunn N; Cancer Alliance Queensland, Metro South Hospital and Health Service, Princess Alexandra Hospital, Brisbane, Australia.
  • Youl P; Cancer Alliance Queensland, Metro South Hospital and Health Service, Princess Alexandra Hospital, Brisbane, Australia.
  • Moore J; Cancer Alliance Queensland, Metro South Hospital and Health Service, Princess Alexandra Hospital, Brisbane, Australia.
  • Harden H; Cancer Alliance Queensland, Metro South Hospital and Health Service, Princess Alexandra Hospital, Brisbane, Australia.
  • Walpole E; Cancer Alliance Queensland, Metro South Hospital and Health Service, Princess Alexandra Hospital, Brisbane, Australia.
  • Evans E; The Wesley Hospital, Brisbane, Australia.
  • Taylor K; BreastScreen Queensland, Metro Southside Service, Archerfield, Australia.
  • Philpot S; Cancer Alliance Queensland, Metro South Hospital and Health Service, Princess Alexandra Hospital, Brisbane, Australia.
  • Furnival C; Cancer Alliance Queensland, Metro South Hospital and Health Service, Princess Alexandra Hospital, Brisbane, Australia.
J Med Screen ; 28(2): 193-199, 2021 06.
Article en En | MEDLINE | ID: mdl-32842857
OBJECTIVE: In the context of a mature mammographic screening programme, the aim of this population-based study was to estimate rates of breast-cancer mortality among participants versus non-participants in Queensland, Australia. METHODS: The Queensland Electoral Roll was used to identify women aged 50-65 in the year 2000 (n = 269,198). Women with a prior history of invasive or in situ breast cancer were excluded (n = 6,848). The study population was then linked to mammography records from BreastScreen Queensland together with the Wesley Breast Screening Clinic (the largest provider of private screening in Queensland) to establish a screened cohort (n = 187,558) and an unscreened cohort (n = 74,792). Cohort members were matched and linked to cancer notifications and deaths through the state-based Queensland Oncology Repository. Differences in breast-cancer mortality between the two cohorts were measured using Cox proportional hazards regression. RESULTS: After 16 years of follow-up, women in the screened cohort showed a 39% reduction in breast-cancer mortality compared to the unscreened cohort (HR = 0.61, 95%CI = 0.55-0.68). Cumulative mortality over the same period was 0.47% and 0.77% in the screened and unscreened cohorts, respectively. CONCLUSIONS: This study found a significant reduction in breast-cancer mortality for women who participated in mammographic screening compared to unscreened women. Our findings of a breast-cancer mortality benefit for women who have mammographic screening are in line with other observational studies.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Mamografía Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Screening_studies Límite: Female / Humans País como asunto: Oceania Idioma: En Año: 2021 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Mamografía Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Screening_studies Límite: Female / Humans País como asunto: Oceania Idioma: En Año: 2021 Tipo del documento: Article